Lack of clinical manifestations in asymptomatic dengue infection is attributed to broad down-regulation and selective up-regulation of host defence response genes
Objectives: Dengue represents one of the most serious life-threatening vector-borne infectious diseases that afflicts approximately 50 million people across the globe annually. Whilst symptomatic infections are frequently reported, asymptomatic dengue remains largely unnoticed. Therefore, we sought...
Published in: | PLoS ONE |
---|---|
Main Author: | |
Format: | Article |
Language: | English |
Published: |
Public Library of Science
2014
|
Online Access: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84899647893&doi=10.1371%2fjournal.pone.0092240&partnerID=40&md5=e5e3f89f81f7f90da2bd8816003a9061 |
id |
2-s2.0-84899647893 |
---|---|
spelling |
2-s2.0-84899647893 Yeo A.S.L.; Azhar N.A.; Yeow W.; Talbot Jr. C.C.; Khan M.A.; Shankar E.M.; Rathakrishnan A.; Azizan A.; Wang S.M.; Lee S.K.; Fong M.Y.; Manikam R.; Sekaran S.D. Lack of clinical manifestations in asymptomatic dengue infection is attributed to broad down-regulation and selective up-regulation of host defence response genes 2014 PLoS ONE 9 4 10.1371/journal.pone.0092240 https://www.scopus.com/inward/record.uri?eid=2-s2.0-84899647893&doi=10.1371%2fjournal.pone.0092240&partnerID=40&md5=e5e3f89f81f7f90da2bd8816003a9061 Objectives: Dengue represents one of the most serious life-threatening vector-borne infectious diseases that afflicts approximately 50 million people across the globe annually. Whilst symptomatic infections are frequently reported, asymptomatic dengue remains largely unnoticed. Therefore, we sought to investigate the immune correlates conferring protection to individuals that remain clinically asymptomatic. Methods: We determined the levels of neutralizing antibodies (nAbs) and gene expression profiles of host immune factors in individuals with asymptomatic infections, and whose cognate household members showed symptoms consistent to clinical dengue infection. Results: We observed broad down-regulation of host defense response (innate, adaptive and matrix metalloprotease) genes in asymptomatic individuals as against symptomatic patients, with selective up-regulation of distinct genes that have been associated with protection. Selected down-regulated genes include: TNF α (TNF), IL8, C1S, factor B (CFB), IL2, IL3, IL4, IL5, IL8, IL9, IL10 and IL13, CD80, CD28, and IL18, MMP8, MMP10, MMP12, MMP15, MMP16, and MMP24. Selected up-regulated genes include: RANTES (CCL5), MIP-1α (CCL3L1/CCL3L3), MIP-1β (CCL4L1), TGFβ (TGFB), and TIMP1. Conclusion: Our findings highlight the potential association of certain host genes conferring protection against clinical dengue. These data are valuable to better explore the mysteries behind the hitherto poorly understood immunopathogenesis of subclinical dengue infection. © 2014 Yeo et al. Public Library of Science 19326203 English Article All Open Access; Gold Open Access |
author |
Yeo A.S.L.; Azhar N.A.; Yeow W.; Talbot Jr. C.C.; Khan M.A.; Shankar E.M.; Rathakrishnan A.; Azizan A.; Wang S.M.; Lee S.K.; Fong M.Y.; Manikam R.; Sekaran S.D. |
spellingShingle |
Yeo A.S.L.; Azhar N.A.; Yeow W.; Talbot Jr. C.C.; Khan M.A.; Shankar E.M.; Rathakrishnan A.; Azizan A.; Wang S.M.; Lee S.K.; Fong M.Y.; Manikam R.; Sekaran S.D. Lack of clinical manifestations in asymptomatic dengue infection is attributed to broad down-regulation and selective up-regulation of host defence response genes |
author_facet |
Yeo A.S.L.; Azhar N.A.; Yeow W.; Talbot Jr. C.C.; Khan M.A.; Shankar E.M.; Rathakrishnan A.; Azizan A.; Wang S.M.; Lee S.K.; Fong M.Y.; Manikam R.; Sekaran S.D. |
author_sort |
Yeo A.S.L.; Azhar N.A.; Yeow W.; Talbot Jr. C.C.; Khan M.A.; Shankar E.M.; Rathakrishnan A.; Azizan A.; Wang S.M.; Lee S.K.; Fong M.Y.; Manikam R.; Sekaran S.D. |
title |
Lack of clinical manifestations in asymptomatic dengue infection is attributed to broad down-regulation and selective up-regulation of host defence response genes |
title_short |
Lack of clinical manifestations in asymptomatic dengue infection is attributed to broad down-regulation and selective up-regulation of host defence response genes |
title_full |
Lack of clinical manifestations in asymptomatic dengue infection is attributed to broad down-regulation and selective up-regulation of host defence response genes |
title_fullStr |
Lack of clinical manifestations in asymptomatic dengue infection is attributed to broad down-regulation and selective up-regulation of host defence response genes |
title_full_unstemmed |
Lack of clinical manifestations in asymptomatic dengue infection is attributed to broad down-regulation and selective up-regulation of host defence response genes |
title_sort |
Lack of clinical manifestations in asymptomatic dengue infection is attributed to broad down-regulation and selective up-regulation of host defence response genes |
publishDate |
2014 |
container_title |
PLoS ONE |
container_volume |
9 |
container_issue |
4 |
doi_str_mv |
10.1371/journal.pone.0092240 |
url |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84899647893&doi=10.1371%2fjournal.pone.0092240&partnerID=40&md5=e5e3f89f81f7f90da2bd8816003a9061 |
description |
Objectives: Dengue represents one of the most serious life-threatening vector-borne infectious diseases that afflicts approximately 50 million people across the globe annually. Whilst symptomatic infections are frequently reported, asymptomatic dengue remains largely unnoticed. Therefore, we sought to investigate the immune correlates conferring protection to individuals that remain clinically asymptomatic. Methods: We determined the levels of neutralizing antibodies (nAbs) and gene expression profiles of host immune factors in individuals with asymptomatic infections, and whose cognate household members showed symptoms consistent to clinical dengue infection. Results: We observed broad down-regulation of host defense response (innate, adaptive and matrix metalloprotease) genes in asymptomatic individuals as against symptomatic patients, with selective up-regulation of distinct genes that have been associated with protection. Selected down-regulated genes include: TNF α (TNF), IL8, C1S, factor B (CFB), IL2, IL3, IL4, IL5, IL8, IL9, IL10 and IL13, CD80, CD28, and IL18, MMP8, MMP10, MMP12, MMP15, MMP16, and MMP24. Selected up-regulated genes include: RANTES (CCL5), MIP-1α (CCL3L1/CCL3L3), MIP-1β (CCL4L1), TGFβ (TGFB), and TIMP1. Conclusion: Our findings highlight the potential association of certain host genes conferring protection against clinical dengue. These data are valuable to better explore the mysteries behind the hitherto poorly understood immunopathogenesis of subclinical dengue infection. © 2014 Yeo et al. |
publisher |
Public Library of Science |
issn |
19326203 |
language |
English |
format |
Article |
accesstype |
All Open Access; Gold Open Access |
record_format |
scopus |
collection |
Scopus |
_version_ |
1818940563836108800 |